Animal Health/Veterinary applications
Currently, Artemisia annua is used in the companion animal segment, specifically, capsules containing Artemisia annua extract are used as effective treatment for uncomplicated leishmaniasis in dogs. With more pet owners willing to pay for veterinary care, the demand for supplements and other treatment options for companion animals is growing.
As within the human population, incidence of chronic skin disorders are growing in both companion pets and livestock, increasing the demand for anti-inflammatory and anti-infective agents.
Additionally, greater instances of animal disease outbreaks coupled with large-scale factory farming means Artennua could potentially be used in feed additives and pharmaceuticals owing to its antibacterial, antiviral, antiparasitic and antifungal properties. Overall, this market is poised to reach 43 billion euros by 2027.
